Effects of Hamo NK hard capsule on experimental atherosclerosis model
Nội dung chính của bài viết
Tóm tắt
This study evaluated the effects of Hamo NK hard capsule on athresclerosis using experimental atherosclerosis model. NewZealand White rabbits were fed a high-fat diet (HFD) containing cholesterol and peanut oil. The animals received oral administration of HFD and Hamo NK hard capsule at two doses of 0.126 and 0.378 g/kg bw/day for 8 consecutive weeks. Blood samples were collected for analyis of biochemical parameters at before treatment, week 4 and week 8. Histopathology assessments of the aortic artery and liver were carried out at the end of the experiment. Hamo NK was effective in reducing serum triglyceride level after 8 weeks of the experiment. In addition, Hamo NK at two doses of 0.126 g/kg b.w and 0.378 g/kg b.w for 8 consecutive weeks did not affect the cholesterol, LDL-C and HDL-C concentrations induced by a HFD. Hamo NK at the dose of 0.126 g/kg bw/day was not only able to decrease significant aortic surface lesions but also capable of managing atherosclerosis plaques formation in aorta; whereas theses activities were not notiaceable at the dose of 0.378 g/kg b.w.
Chi tiết bài viết
Từ khóa
Hamo NK hard capsule, experimental atherosclerosis model, high-fat diet.
Tài liệu tham khảo
2. Lusis AJ. Atherosclerosis. Nature. 2000;407(6801):233-241. doi:10.1038/35025203
3. Gorelick Philip B., Goldstein Larry B., Ovbiagele Bruce. New Guidelines to Reduce Risk of Atherosclerotic Cardiovascular Disease. Stroke. 2014;45(4):945-947. doi:10.1161/STROKEAHA.114.004560
4. Ohsfeldt RL, Gandhi SK, Fox KM, Bullano MF, Davidson M. Medical and cost burden of atherosclerosis among patients treated in routine clinical practice. Journal of Medical Economics. 2010;13(3):500-507. doi:10.3111/13696998.2010.506348
5. Liu Q, Li J, Hartstone-Rose A, et al. Chinese Herbal Compounds for the Prevention and Treatment of Atherosclerosis: Experimental Evidence and Mechanisms. Evidence-Based Complementary and Alternative Medicine. doi:https://doi.org/10.1155/2015/752610
6. Fan J, Kitajima S, Watanabe T, et al. Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine. Pharmacol Ther. 2015;0:104-119. doi:10.1016/j.pharmthera.2014.09.009
7. Yu J-J, Su J, Yan M-Q, Lou Z-H, Lyu G-Y. [Correlation between lipid-lowering efficacy and components of Pericarpium Citri Reticulatae]. Zhongguo Zhong Yao Za Zhi. 2019;44(15):3335-3342. doi:10.19540/j.cnki.cjcmm.20190523.304
8. Guo M, Liu Y, Gao Z-Y, Shi D. Chinese Herbal Medicine on Dyslipidemia: Progress and Perspective. Evidence-Based Complementary and Alternative Medicine. 2014;2014:e163036. doi:10.1155/2014/163036
9. Yang Z, Liu Y, Deng W, et al. Hesperetin attenuates mitochondria-dependent apoptosis in lipopolysaccharide-induced H9C2 cardiomyocytes. Molecular Medicine Reports. 2014;9(5):1941-1946. doi:10.3892/mmr.2014.2002
10. Ou L, Sun X, Liu Q, Mi S, Wang N. Effects of Rhizoma zingiberis and Pericarpium citri reticulatae extracts on myocardial ischemia in rats. Zhong Yao Cai. 2009;32(11):1723-1726.
11. Yang L, Hou A-J, Yan M-L, et al. Investigation of radix achyranthis bidentatae phytochemistry and pharmacology. World Journal of Traditional Chinese Medicine. 2019;5:50. doi:10.4103/wjtcm.wjtcm_25_18
12. Lin H-Y, Kuo Y-H, Lin Y-L, Chiang W. Antioxidative Effect and Active Components from Leaves of Lotus (Nelumbo nucifera). J Agric Food Chem. 2009;57(15):6623-6629. doi:10.1021/jf900950z